JPMC partners with stem cell banking pioneer

Aziz Idris

Jerudong Park Medical Centre (JPMC) together with Stemlife Berhad – the pioneer and largest cord blood bank in Malaysia – has opened a Stem Cell Banking Resource Centre.

The centre is located in the Obstetrics and Gynaecology Clinic at Level 3 of JPMC.

The room provides convenient access for expectant families to gather information about the lifesaving clinical applications of stem cells from cord blood and the umbilical cord, before or after the consultation with their obstetrician.

This setting allows expectant families to make an informed decision before the arrival of their baby.

“JPMC and Stemlife have enjoyed working relations since our foundational partnership in 2016. The newly opened Stemlife Stem Cell Banking Resource Centre within JPMC facility will strengthen our operational efficiency to meet the rising demand for stem cell banking among expectant parents in Brunei.

Medical Director of Jerudong Park Medical Centre (JPMC) Dr Meera Sahib Kabeer and Chief Operating Officer of Stemlife Berhad Zahrein Redza during the ribbon-cutting ceremony. PHOTO: JPMC

“Bruneians can also enjoy the confidence knowing that they are receiving the world-class standard services jointly provided by Stemlife and JPMC,” said Medical Director of JPMC Dr Meera Sahib Kabeer.

“This collaboration exemplifies Stemlife’s longstanding commitment to expand our geographical footprints in Asia and to offer internationally accredited cord blood banking services to expectant families in the region.

“American Association of Blood Bank (AABB) is the de facto international quality yardstick in the industry and most transplant physicians around the world trust that cord blood handed by AABB accredited banks were properly collected, tested, processed and stored in a way that is consistent with enhancing the chances of a successful transplant.

“This accreditation strengthens the confidence of Bruneian clients, reassuring them that their babies’ cord blood will be properly handled and carefully cryopreserved for future medical use,” said Chief Operating Officer of Stemlife Berhad Zahrein Redza.